drugset / Trial / NCT00783042

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

NCT00783042

Phase 0 Completed 80 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The aim of this study is to investigate whether the non-invasive ultrasound method for assessment of coronary blood flow, transthoracic Doppler echocardiography-coronary flow reserve (TTDE-CFR), can be used to measure drug effects.

Timeline

Start
2008-10
Primary completion
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosuvastatin Small molecule 40 mg Oral